SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Implant Today.
MRI Ready Tomorrow.*

Implant Today. MRI Ready Tomorrow*

Our Abbott CRT devices, ICDs, ICMs, pacemakers and pacing leads allow full body, 1.5T and 3T MRI scans* ensuring your patients can get the care they need, when they need it.
 

% OF MRI SCANS ARE URGENT OR EMERGENT:

22.7%1

22.7% of MRI scans are urgent or emergent

IFU RECOMMENDED WAIT TIME FOR MRI SCAN:

42
DAYS

For Medtronic, Boston Scientific and Biotronik2-4

NO
WAIT


For Abbott*
IFU Recommended wait time for MRI scan

The 2021 ESC guidelines recommend to follow manufacturer instructions to perform MRI exams in patients with MRI-conditional systems.5

Changes in cardiac pacing and cardiac resynchronization
therapy guideline recommendations since 2013
Management considerationsClassa 2021Classa 2021
In patients with MRI-conditional pacemaker systemsb, MRI can be performed safely following manufacturer instructions.IIaI
In patients with non-MRI-conditional pacemaker systems, MRI should be considered if no alternative imaging mode is available and if no epicardial leads, abandoned or damaged leads, or lead adaptors/extenders are present.IIbIIa

 

a Class of recommendation.
b Combination of MRI conditional generator and lead(s) from the same manufacturer.

No Wait MRI Allows Timely Diagnosis for Patients

See how one patient’s ischemic stroke was diagnosed within an hour of an Assurity MRI™ pacemaker implant. The quick diagnosis allowed the doctor to prescribe appropriate treatment and medication for the patient without delay.

 

Continuously-Improving Technology Helps You Provide Even Better Care for Your Patients.

Abbott provides a full portfolio of cardiac devices for immediate access to both 3T and 1.5T MRI scans.* Eliminate the six-week wait time for MRI scans that Medtronic, Boston Scientific and Biotronik recommend.

  • Meets industry-standard MRI testing parameters
  • Shortest delay between implantation and scan feasibility on the market for pacemakers.2-4
  • MR Conditional for full body 1.5T and 3T MRI scans*
continuously-improving technology
continuously-improving technology
Gallant™, Neutrino™ NXT, Entrant™, Assurity MRI™, Endurity MRI™, Confirm RX™ - MR Conditional Features**
MAGENT (TESLA)1.5T and 3T
SCAN TYPEFULL-BODY
SCANNER MODENORMAL OPERATING MODE

Talk to Your Sales Rep About All No Wait MRI Has to Offer

talk to your sales rep
talk to your sales rep

MRI-Ready Solutions

Gallant HF

Gallant™ ICD / CRT-D

Assurity Pacemaker

Assurity™ MRI Pacemaker

Endurity Pacemaker

Endurity™ Pacemaker

Assurity Pacemaker

Confirm Rx™ ICM


These devices are commercially available for use in select international markets.

Search for MRI Scan Parameters

Search for MRI Scan Parameters

* No minimum length of time requirement between implant and MRI scan. Stability of pacing capture thresholds is required prior to MRI scan.

**For additional information about specific MR Conditional and lead model numbers, including warnings, precautions, adverse conditions to MRI scanning and potential adverse events, please refer to the MRI-Ready Systems Manual at medical.abbott/manuals.

References

  1. Strom JB, Whelan JB, Shen C, Zheng SQ, Mortele KJ, Kramer DB. Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices. Heart Rhythm. 2017;14(8):1138-1144. doi:10.1016/j.hrthm.2017.03.039
  2. Medtronic. Medtronic Azure™ MRI Surescan™/Astra™ MRI Surescan™ pacing systems MRI technical manual. 2016 Medtronic, M964377A001 B. Accessed December 18, 2020.
  3. Boston Scientifi c. Imageready™ MR Conditional Pacing Systems MRI technical guide. Boston Scientifi c, 360167-003 EN US 2019-07. Accessed December 18, 2020.
  4. Biotronik. ProMRI System Technical Manual. Biotronik, 5/13/20, MN062r11. Accessed January 11, 2020.
  5. Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg, Yoav Michowitz, Angelo Auricchio, Israel Moshe Barbash, José A Barrabés, Giuseppe Boriani, Frieder Braunschweig, Michele Brignole, Haran Burri, Andrew J S Coats, Jean-Claude Deharo, Victoria Delgado, Gerhard-Paul Diller, Carsten W Israel, Andre Keren, Reinoud E Knops, Dipak Kotecha, Christophe Leclercq, Béla Merkely, Christoph Starck, Ingela Thylén, José Maria Tolosana, ESC Scientific Document Group, 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA), European Heart Journal, Volume 42, Issue 35, 14 September 2021, Pages 3427–3520, https://doi.org/10.1093/eurheartj/ehab364

MAT-2202578 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0